OnkoRadar

An application supporting the OnkoRadar oncological prevention program, prepared by Wellysa and the Read-Gene group.

OnkoRadar is a unique medical service. Conveniently and at an affordable price, perform an oncological risk analysis based on key clinical, pedigree and molecular criteria. Your quick way to control and reduce the risk of cancer.

OnkoRadar package, i.e.:
- Analysis of family oncological history.
- Testing for common oncological genetic mutations (BRCA1, CHEK2, PALB2, NBS1).
- Testing the concentration of key microelements responsible for the early detection of cancer (Selenium, Arsenic, Zinc).
- Specialist teleconsultation with professors for diagnosed DNA mutations, up to 28 days from confirmation of the mutation.
- Convenient access to results via the OnkoRadar application.

Modern cancer prevention:
Medicine knows more and more causes of cancer, but this knowledge is not easily accessible and understandable to the average person, and therefore is not widely used for individual prevention. We detect cancer too late, so their treatment is less effective.

Cancer is the second leading cause of death in Poland (after circulatory system diseases), accounting for approximately ¼ of deaths. The results of genetic tests have shown that every third person in Poland is a carrier of a genetic mutation**

Moreover, according to the latest scientific publications, abnormal levels of important microelements, such as Selenium, Arsenic or Zinc, may be responsible for the earlier manifestation of oncological diseases.

The extensive knowledge and many years of clinical experience of Read-Gene, an internationally renowned cancer prevention center, have been collected and presented in the form of a simple, friendly mobile application, available to everyone, created by Wellysa.

* https://onkologia.org.pl/pl/epidemiologia/zdrowie-zlosliwy-w-polsce
** DNA ERA press materials

High quality:
OnkoRadar offers the highest quality of medical analyzes and procedures, guaranteed by a team of internationally renowned oncogenetics professors. Many of the research methods used in OnkoRadar are covered by the patent protection of Read-Gene SA.

Simple process:
1) Download the OnkoRadar application
2) Purchase the service
3) Complete the family oncological history survey in the application.
4) Go to a nearby laboratory to donate blood for testing.
5) Your samples will go to Read-Gene SA, where it will be checked whether you have oncological DNA mutations and your concentration of key microelements.
6) All results will be analyzed and assessed by the Professor's team and then provided to you within up to 4 weeks in the form of a specialized digital medical report.
7) If there are medical indications, you will receive an invitation for another blood collection and test.
8) If there are medical indications, you will receive an additional professorial teleconsultation with an oncogeneticist who will explain the results and further medical procedure.